Indivina 1 mg / 5 mg tabletti Suomi - suomi - Fimea (Suomen lääkevirasto)

indivina 1 mg / 5 mg tabletti

orion corporation - estradiol valerate, medroxyprogesterone acetate - tabletti - 1 mg / 5 mg - medroksiprogesteroni ja estrogeeni

Indivina 2 mg / 5 mg tabletti Suomi - suomi - Fimea (Suomen lääkevirasto)

indivina 2 mg / 5 mg tabletti

orion corporation - estradiol valerate, medroxyprogesterone acetate - tabletti - 2 mg / 5 mg - medroksiprogesteroni ja estrogeeni

Cliovelle 1 mg / 0,5 mg tabletti Suomi - suomi - Fimea (Suomen lääkevirasto)

cliovelle 1 mg / 0,5 mg tabletti

dr. kade pharmazeutische fabrik gmbh - norethisterone acetate, estradiol valerate - tabletti - 1 mg / 0,5 mg - noretisteroni ja estrogeeni

ANAGRELIDE AOP 0.5 mg kapseli, kova Suomi - suomi - Fimea (Suomen lääkevirasto)

anagrelide aop 0.5 mg kapseli, kova

aop orphan pharmaceuticals ag - anagrelidi hydrochloridum,anagrelidi hydrochloridum monohydricum - kapseli, kova - 0.5 mg - anagrelidi

Blenrep Euroopan unioni - suomi - EMA (European Medicines Agency)

blenrep

glaxosmithkline (ireland) limited - belantamab mafodotin - multiple myeloma - antineoplastiset aineet - blenrep is indicated as monotherapy for the treatment of multiple myeloma in adult patients, who have received at least four prior therapies and whose disease is refractory to at least one proteasome inhibitor, one immunomodulatory agent, and an anti-cd38 monoclonal antibody, and who have demonstrated disease progression on the last therapy.

Iclusig Euroopan unioni - suomi - EMA (European Medicines Agency)

iclusig

incyte biosciences distribution b.v. - ponatinib - leukemia, myeloid; leukemia, lymphoid - antineoplastic agents, protein kinase inhibitors - iclusig is indicated in adult patients withchronic phase, accelerated phase, or blast phase chronic myeloid leukaemia (cml) who are resistant to dasatinib or nilotinib; who are intolerant to dasatinib or nilotinib and for whom subsequent treatment with imatinib is not clinically appropriate; or who have the t315i mutationphiladelphia chromosome positive acute lymphoblastic leukaemia (ph+ all) who are resistant to dasatinib; who are intolerant to dasatinib and for whom subsequent treatment with imatinib is not clinically appropriate; or who have the t315i mutation. katso kohdat 4. 2 assessment of cardiovascular status prior to start of therapy and 4. 4 situations where an alternative treatment may be considered.

Xanor 0.25 mg tabletti Suomi - suomi - Fimea (Suomen lääkevirasto)

xanor 0.25 mg tabletti

upjohn eesv - alprazolam - tabletti - 0.25 mg - alpratsolaami

Xanor 0.5 mg tabletti Suomi - suomi - Fimea (Suomen lääkevirasto)

xanor 0.5 mg tabletti

upjohn eesv - alprazolam - tabletti - 0.5 mg - alpratsolaami

Xanor 1 mg tabletti Suomi - suomi - Fimea (Suomen lääkevirasto)

xanor 1 mg tabletti

upjohn eesv - alprazolam - tabletti - 1 mg - alpratsolaami

Xanor 2 mg tabletti Suomi - suomi - Fimea (Suomen lääkevirasto)

xanor 2 mg tabletti

upjohn eesv - alprazolam - tabletti - 2 mg - alpratsolaami